Article info

Download PDFPDF
Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data

Authors

  • Stephan Polterauer Division General Gynaecology and Gynaecological Oncology, Department of Obstetrics and Gynaecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria; PubMed articlesGoogle scholar articles
  • Ignace Vergote Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; PubMed articlesGoogle scholar articles
  • Nicole Concin Department of Obstetrics and Gynaecology, Innsbruck Medical University, Tirol, Austria; PubMed articlesGoogle scholar articles
  • Ioana Braicu Departmentof Gynaecology, European Competence Center for Ovarian Cancer,Campus Virchow Klinikum, Charité–Universitätsmedizin Berlin,Berlin; PubMed articlesGoogle scholar articles
  • Radoslav Chekerov Departmentof Gynaecology, European Competence Center for Ovarian Cancer,Campus Virchow Klinikum, Charité–Universitätsmedizin Berlin,Berlin; PubMed articlesGoogle scholar articles
  • Sven Mahner Department of Gynaecology and Gynaecologic Oncology,University Medical Center Hamburg-Eppendorf, Hamburg, Germany; PubMed articlesGoogle scholar articles
  • Linn Woelber Department of Gynaecology and Gynaecologic Oncology,University Medical Center Hamburg-Eppendorf, Hamburg, Germany; PubMed articlesGoogle scholar articles
  • Isabelle Cadron Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; PubMed articlesGoogle scholar articles
  • Toon Van Gorp Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; GROW–School for Oncology and DevelopmentalBiology, Maastricht University Medical Centre, Maastricht, the Netherlands; and PubMed articlesGoogle scholar articles
  • Robert Zeillinger Division General Gynaecology and Gynaecological Oncology, Department of Obstetrics and Gynaecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria; Ludwig Boltzmann Cluster Translational Oncology, General Hospital of Vienna, Vienna, Austria. PubMed articlesGoogle scholar articles
  • Dan Cacsire Castillo-Tong Division General Gynaecology and Gynaecological Oncology, Department of Obstetrics and Gynaecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria; Ludwig Boltzmann Cluster Translational Oncology, General Hospital of Vienna, Vienna, Austria. PubMed articlesGoogle scholar articles
  • Jalid Sehouli Departmentof Gynaecology, European Competence Center for Ovarian Cancer,Campus Virchow Klinikum, Charité–Universitätsmedizin Berlin,Berlin; PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Stephan Polterauer, MD, Division General Gynaecology and Gynaecological Oncology, Department of Obstetrics and Gynaecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. E-mail: stephan.polterauer{at}meduniwien.ac.at.

Citation

Polterauer S, Vergote I, Concin N, et al
Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data

Publication history

  • Received May 24, 2011
  • Accepted October 19, 2011
  • First published March 1, 2012.
Online issue publication 
June 17, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.